Bioxytran (BIXT) Net Income (2010 - 2026)
Bioxytran (BIXT) recorded Net Income of -$619,929 in Q2 2026, compared with $35,439 a year earlier.
Powered by 
Analysis
Bioxytran (BIXT) Net Income (2010 - 2026) Analysis & Trends
On a TTM basis, Bioxytran's Net Income came in at -$3.49 million as of Jun 30, 2026; for FY2025, it was -$2.12 million.
- Across earlier years, Net Income came in at -$2.38 million in FY2024, -$4.56 million in FY2023, -$2.67 million in FY2022 and -$4.53 million in FY2021.
- Quarterly Net Income has ranged from -$2.07 million in Q1 2026 to $35,439 in Q2 2025 over the past five years.
- Per Business Quant, the preceding three quarters came in at -$2.07 million (Q1 2026), -$522,155 (Q4 2025) and -$282,726 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 5.53 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 3.62 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -1.34 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 3.26 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 2.51 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 2.38 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -10.50 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -237.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 1.10 Bn |
| 10 | Bioxytran | 2.29 Mn | 1.13 Mn | - | -619,929.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -619,929.00 |
| Mar 31, 2026 | -2.07 Mn |
| Dec 31, 2025 | -522,155.00 |
| Sep 30, 2025 | -282,726.00 |
| Jun 30, 2025 | 35,439.00 |
| Mar 31, 2025 | -1.35 Mn |
| Dec 31, 2024 | -752,138.00 |
| Sep 30, 2024 | -392,374.00 |
| Jun 30, 2024 | -661,647.00 |
| Mar 31, 2024 | -573,846.00 |
| Dec 31, 2023 | -1.17 Mn |
| Sep 30, 2023 | -1.13 Mn |
| Jun 30, 2023 | -1.45 Mn |
| Mar 31, 2023 | -817,977.00 |
| Dec 31, 2022 | -865,932.00 |
| Sep 30, 2022 | -203,149.00 |
| Jun 30, 2022 | -634,040.00 |
| Mar 31, 2022 | -963,386.00 |
| Dec 31, 2021 | -998,403.00 |
| Sep 30, 2021 | -609,682.00 |
API Access
Bioxytran Net Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-income&ticker=BIXT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-income", "ticker": "BIXT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-income&ticker=BIXT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();